Stocktoria
NUTRA PHARMA CORP NPHC
OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2001-10-09
NUTRA PHARMA CORP statistics & valuation
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 76.3% | 100.4% | — | — | 8.7% | 28.7% | 33.3% | 10.8% | 77.8% | -32.5% |
| Operating margin | -567.7% | -356.6% | -431.5% | -1308.2% | -2034.5% | -1782.3% | -1178.1% | -1438.7% | -1142.3% | -1213.8% |
| Net margin | -794.8% | -522.0% | -677.8% | 5608.3% | -13399.0% | -1482.1% | -6314.1% | -2974.6% | -3330.1% | -2047.8% |
| FCF margin | -461.9% | — | — | -562.7% | -1824.8% | -1703.4% | — | — | -948.5% | -807.7% |
| Return on assets | -350.2% | -214.5% | -217.6% | 1083.2% | -1678.9% | -254.9% | -1939.6% | -2747.0% | -1034.2% | -1609.1% |
| Return on equity | 12.2% | 8.7% | 10.1% | -66.1% | 62.7% | 6.7% | 56.3% | 65.4% | 74.5% | 77.0% |
| Debt / equity | -0.58× | -0.58× | -0.62× | -0.66× | — | -0.02× | — | -0.01× | — | — |
| Current ratio | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.00 | 0.01 | 0.02 | 0.06 | 0.04 |
Source: SEC EDGAR filings · CIK 0001119643 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.